BBIO - BridgeBio Pharma, Inc.
66.54
2.010 3.021%
Share volume: 2,388,808
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$64.53
2.01
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-02-2024 | 08-01-2024 | 11-12-2024 | 02-20-2025 | 04-29-2025 | 08-05-2025 | 10-29-2025 | 02-24-2026 | |
| Assets | |||||||||
| Total Assets | 849.333 M | 794.375 M | 664.977 M | 919.338 M | 881.638 M | 1.080 B | 998.250 M | 936.025 M | |
| Current Assets | 783.424 M | 616.236 M | 444.578 M | 720.692 M | 695.173 M | 912.277 M | 839.382 M | 797.749 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 3.954 M | 18.277 M | 24.527 M | 26.753 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 44.469 M | 39.813 M | 0.000 | 0.000 | 0.000 | 7.939 M | 2.991 M | 17.363 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 4.722 M | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 475.222 M | 407.958 M | 266.324 M | 681.101 M | 540.599 M | 748.953 M | 642.951 M | 570.119 M | |
| Total Non-current Assets | 0.000 | 117.006 M | 160.443 M | 143.747 M | 128.191 M | 108.002 M | 92.168 M | 79.972 M | |
| Property Plant Equipment | 11.414 M | 9.840 M | 8.701 M | 7.011 M | 6.698 M | 6.107 M | 5.830 M | 5.366 M | |
| Other Assets | 54.495 M | 168.299 M | 211.698 M | 191.635 M | 179.767 M | 161.806 M | 153.038 M | 132.910 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 849.333 M | 794.375 M | 664.977 M | 919.338 M | 881.638 M | 1.080 B | 998.250 M | 936.025 M | |
| Total liabilities | 1.886 B | 1.876 B | 1.883 B | 2.377 B | 2.520 B | 2.859 B | 2.921 B | 3.013 B | |
| Total current liabilities | 141.477 M | 134.364 M | 139.216 M | 154.400 M | 152.105 M | 175.854 M | 216.600 M | 287.971 M | |
| Accounts Payable | 4.728 M | 18.126 M | 13.363 M | 9.618 M | 27.525 M | 26.134 M | 18.702 M | 36.228 M | |
| Other liabilities | 1.290 B | 1.290 B | 1.289 B | 1.768 B | 2.351 B | 2.668 B | 840.232 M | 859.085 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 434.717 M | 435.447 M | 436.221 M | 437.337 M | 0.000 | 0.000 | 1.851 B | 1.852 B | |
| Other liabilities | 1.290 B | 1.290 B | 1.289 B | 1.768 B | 2.351 B | 2.668 B | 840.232 M | 859.085 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -1.050 B | -1.093 B | -1.230 B | -1.468 B | -1.648 B | -1.788 B | -1.933 B | -2.087 B | |
| Common stock | 1.821 B | 1.851 B | 1.876 B | 1.903 B | 1.939 B | 1.981 B | 2.019 B | 2.058 B | |
| Retained earnings | -2.596 B | -2.669 B | -2.831 B | -3.096 B | -3.264 B | -3.446 B | -3.628 B | -3.821 B |